April 29, 2026 | NYC


Food Allergy Fund Summit

Join us for the premier gathering shaping the future of food allergy research and innovation. The annual Food Allergy Fund Summit connects the brightest minds across science, policy, and investment to turn breakthroughs into action.

April 29, 2026 | 9:00 a.m. – 12:30 p.m.
Paley Center for Media | New York, NY


Post-Summit Exclusive Luncheon

Immediately following our signature Summit, continue the conversation and connect with researchers and CEOs from around the world advancing food allergy research and solutions over lunch.

April 29, 2026 | 1:00 p.m. – 3:00 p.m.
The Modern | New York, NY

*

Meet the 2026 Summit Speakers

* Meet the 2026 Summit Speakers

  • Arianna Huffington

    Arianna Huffington

    Founder & CEO, Thrive Global

  • Dr. Becky Kennedy

    Founder & CEO, Good Inside

  • Dr. Jennifer Wallace

    Dr. Jennifer Wallace

    Journalist and New York Times best-selling author of Mattering
    (Post-Summit Luncheon Speaker)

  • Alice Bast

    Alice Bast

    Founder & CEO, Beyond Celiac

  • Dr. David Burkhart

    Dr. David Burkhart

    Co-Founder & CEO, Inimmune

  • Dr. Scott Commins

    Dr. Scott Commins

    William J. Yount Distinguished Professor of Medicine
    Associate Chief for Allergy & Immunology
    UNC School of Health

  • Bertha Coombs

    Fmr Senior Health Care Reporter, CNBC

  • Dr. Lou DeGennaro

    Dr. Lou DeGennaro

    Former CEO, Leukemia and Lymphoma Society,
    Senior Advisor, Vie Ventures

  • Maya Goldman

    Health Reporter, Axios

  • Dr. Stephanie Eisenbarth

    Dr. Stephanie Eisenbarth

    Director, Center for Human Immunobiology
    Chief of Allergy and Immunology
    Northwestern University Feinberg School of Medicine

  • Tal Golan

    Tal Golan

    Co-Founder & CEO, Anjo.ai

  • Ilana Golant

    Ilana Golant

    Founder & CEO, Food Allergy Fund

  • Dr. David Hill

    Assistant Professor of Pediatrics
    University of Pennsylvania Perelman School of Medicine

  • Robyn Lao FAF Speaker

    Robyn Lao

    ADDE Act

  • Dr. Uri Lopatin

    CEO, Ukko 

  • Dr. Ariel Munitz

    Dr. Ariel Munitz

    Professor, The Roberts-Guthman Chair in Immunopharmacology
    Department of Clinical Microbiology and Immunology, Tel Aviv University 

  • Michael Osso

    Michael Osso

    President & CEO, Crohn's & Colitis Foundation

  • Dr. Samir Patel

    President & CEO, Moonlight Therapeutics

  • Dr. Nicole Ramsey

    Dr. Nicole Ramsey

    Assistant Professor, Division of Pediatric Allergy and Immunology
    Mount Sinai School of Medicine

  • Dr. Yoni Savir

    Associate Professor, Technion - Israel Institute of Technology

  • Thomas Silvera

    Co-Founder and CEO,
    Elijah-Alavi Foundation, Elijah’s Law

  • Dr. Steven St. Peter

    Dr. Steven St. Peter

    Co-Founder & Managing Director, Vie Ventures

  • Dr. Mimi Tang

    Dr. Mimi Tang

    Scientific Founder and Board Director, Prota Therapeutics

  • Seth Togal

    ADINA Act

  • Dr. Yamini Virkud

    Dr. Yamini Virkud

    Associate Professor of Pediatrics
    Director of UNC FAI Bioinformatics
    UNC School of Health

  • Dr. Joseph Zackular

    Co-Director, Center for Microbial Medicine
    Children’s Hospital of Philadelphia

AGENDA


Fast-tracking Discovery to Treatment: Repurposing Drugs and Accelerating the Path Forward

Dr. Scott Commins, William J. Yount Distinguished Professor of Medicine, Associate Chief for Allergy & Immunology, UNC School of Health 

Dr. Stephanie Eisenbarth, Director, Center for Human Immunobiology, Chief of Allergy and Immunology, Northwestern University Feinberg School of Medicine 

Dr. Nicole Ramsey, Assistant Professor, Division of Pediatric Allergy and Immunology, Mount Sinai School of Medicine 

Dr. Yamini Virkud, Associate Professor of Pediatrics, Director of UNC FAI Bioinformatics, UNC School of Health 

Moderator: Bertha Coombs, Fmr Senior Health Care Reporter, CNBC


A New Funding Model: Venture Philanthropy

Alice Bast, Founder & CEO, Beyond Celiac

Dr. Lou DeGennaro, Former CEO, Leukemia and Lymphoma Society, Senior Advisor, Vie Ventures

Michael Osso, President & CEO, Crohn's & Colitis Foundation

Dr. Steven St. Peter, Co-Founder & Managing Director, Vie Ventures

Moderator: Ilana Golant, Founder & CEO, Food Allergy Fund


Biotech and Translation: Turning Science into Solutions

Presenters:
Dr. David Burkhart, CEO & Co-Founder, Inimmune

Dr. Uri Lopatin, CEO, Ukko

Dr. Samir Patel, President and CEO, Moonlight Therapeutics

Dr. Mimi Tang, Scientific Founder and Board Director, Prota Therapeutics


AI, Immunology, and What Comes Next: Israel’s Startup Nation

Tal Golan, Co-Founder & CEO, Anjo.ai

Dr. Ariel Munitz, Professor, The Roberts-Guthman Chair in Immunopharmacology, Department of Clinical Microbiology and Immunology, Tel Aviv University 

Dr. Yoni Savir, Associate Professor, Technion – Israel Institute of Technology


A System-Level Approach to Understanding the Microbiome’s Role in Food Allergy

Dr. Joseph Zackular, Co-Director, Center for Microbial Medicine, Children’s Hospital of Philadelphia

Dr. David Hill, Assistant Professor of Pediatrics, University of Pennsylvania Perelman School of Medicine


Families Driving Change: From Experience to Policy

Robyn Lao, ADDE Act

Thomas Silvera, Co-Founder & CEO, Elijah-Alavi Foundation, Elijah’s Law

Seth Togal, ADINA Act

Moderator: Maya Goldman, Reporter, Axios


Fireside Chat: Care, Confidence, and the Lived Experience

Dr. Becky Kennedy, Founder & CEO, Good Inside in conversation with Arianna Huffington, Founder & CEO, Thrive Global